Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue SUPPL. A, 1999, Pages 25-30

  Blondeau, J M ^a,b   Suter, M ^a   Borsos, S ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; LORACARBEF; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANADA; HAEMOPHILUS INFLUENZAE; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; CIPROFLOXACIN; HAEMOPHILUS INFLUENZAE; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; PENICILLIN RESISTANCE; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032974621     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Scriver, S. R., Walmsley, S. L., Kau, C. L., Hoban, D. J., Brunton, J., McGeer, A. et al. (1994). Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrobial Agents and Chemotherapy 38, 1678-80.
2. Lonks, J. R. & Medeiros, A. A. (1995). The growing threat of antibiotic-resistant Streptococcus pneumoniae. Medical Clinics of North America 79, 523-35.
3. Catlin, B. W. (1990). Branhamella catarrhalis: an organism gaining respect as a pathogen. Clinical Microbiology Reviews 3, 293-320.
4. Felmingham, D. (1995). Antibiotic resistance. Do we need new therapeutic approaches? Chest 108, Suppl. 2, 70S-8S.
5. Gruneberg, R. N. & Felmingham, D. (1996). Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagnostic Microbiology and Infectious Disease 25, 169-81.
6. Kunin, C. M. (1993). Resistance to antimicrobial drugs - a worldwide calamity. Annals of Internal Medicine 118, 557-61.
7. Doern, G. V., Brueggemann, A. B., Pierce, G., Holley, H. P. & Rauch, A. (1997). Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of β-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrobial Agents and Chemotherapy 41, 292-7.
8. Doern, G. V., Brueggemann, A., Holley, H. P. & Rauch, A. M. (1996). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 1208-13.
9. Doern, G. V., Brueggemann, A. B., Pierce, G., Hogan, T., Holley, H. P. & Rauch, A. (1996). Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrobial Agents and Chemotherapy 40, 2884-6.
10. Simor, A. E., Louie, M., Low, D. E. & the Canadian Bacterial Surveillance Network. (1996). Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 40, 2190-3.
11. Clark, R. B., Giger, O. & Mortensen, J. E. (1993). Comparison of susceptibility test methods to detect penicillin-resistant Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease 17, 213-7.
12. Blondeau, J. M., Yaschuk, Y. & the Canadian Ciprofloxacin Study Group. (1996). Canadian Ciprofloxacin susceptibility study: comparative study from 15 medical centers. Antimicrobial Agents and Chemotherapy 40, 1729-32.
13. National Committee for Clinical Laboratory Standards. (1994). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A7. NCCLS, Villanova, PA.
14. Tremblay, L. D., L'Ecuyer, J., Provencher, P., Bergeron, M. G. & the Canadian Study Group. (1990). Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Medical Association Journal 143, 895-901.
15. Hoban, D. J., Jones, R. N. & the Canadian Ofloxacin Study Group. (1995). Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers. Chemotherapy 41, 34-8.
16. Hoban, D. J., Jones, R. N., Harrell, L. J., Knudson, M. & Sewell, D. (1993). The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance. Diagnostic Microbiology and Infectious Disease 17, 157-61.
17. Baer, M., Vuento, R. & Vesikari, T. (1995). Increase in bacteraemic pneumococcal infections in children. Lancet 345, 661.
18. Foster, J. A. & McGowan, K. L. (1994). Rising rate of pneumococcal bacteremia at the Children's Hospital of Philadelphia. Pediatric Infectious Disease Journal 13, 1143-4.
19. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Disease 15, 77-83.
20. Barry, A. L., Pfaller, M. A., Fuchs, P. C. & Packer, R. R. (1994). In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US Medical Centers in 1992 and 1993. Antimicrobial Agents and Chemotherapy 38, 2419-25.
21. Breiman, R. F., Butler, J. C., Tenover, F. C., Elliott, J. A. & Facklam, R. R. (1994). Emergence of drug-resistant pneumococcal infections in the United States. Journal of the American Medical Association 271, 1831-35.
22. Dixon, J. M., Lipinski, A. E. & Graham, M. E. (1977). Detection and prevalence of pneumococci with increased resistance to penicillin. Canadian Medical Association Journal 117, 1159-61.
23. Jette, L. P. & Lamothe, F. (1989). Surveillance of invasive Streptococcus pneumoniae infection in Quebec, Canada, from 1984 to 1986: serotype distribution, antimicrobial susceptibility, and clinical characteristics. Journal of Clinical Microbiology 27, 1-5.
24. Mazzulli, T., Simor, A. E., Jaeger, R., Fuller, S. & Low, D. E. (1990). Comparative in vitro activities of several new fluoroquinolones and beta-lactam antimicrobial agents against community isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 34, 467-9.
25. Jacobs, M. R., Bajaksouzian, S., Appelbaum, P. C. & Bolmstrom, A. (1992). Evaluation of the Etest for susceptibility testing of pneumococci. Diagnostic Microbiology and Infectious Disease 15, 473-8.
26. Blondeau, J. M., Vaughan, D., Low, D., Graham, C. & Sutor, M. (1997). Regional resistance rates for penicillin resistant Streptococcus pneumoniae (PRSP) in Saskatchewan, Canada. In Proceedings of the Twentieth International Congress of Chemotherapy, Sydney, 1997. Abstract P032-3209, p. 80. Organizing Committee of the International Congress of Chemotherapy, Victoria, Australia.
27. Felmingham, D. & Gruneberg, R. N. (1996). A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. Journal of Antimicrobial Chemotherapy 38, Suppl. A, 1-57.
28. Quinn, J. P. (1989). Mechanism of resistance to beta-lactam antibiotics. Hospital Formulary 24, 204-5.
29. Hakenbeck, R., Tarpay, M. & Tomasz, A. (1980). Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 17, 364-71.